AHA vs BHA: Choosing the Right Acid
SaveBoth acids exfoliate, and beyond that the similarities mostly end. This breaks down what each one actually does differently at the skin level, who tends to benefit more from which, which skin conditions call for caution with both, and how to combine them without overdoing it.
Last updated: July 2026
What AHAs Actually Do
AHAs — alpha hydroxy acids, most commonly glycolic acid and lactic acid — are water-soluble molecules that work primarily on the outermost layer of skin, loosening the bonds between dead skin cells so they shed more evenly. That surface action is why AHAs tend to show up in products aimed at dullness, rough texture, and the kind of fine-line and pigmentation changes associated with sun exposure over time, and why lactic acid specifically is one of the better-supported topical options for bump-prone conditions like keratosis pilaris, alongside salicylic acid and urea 1Ref 1Maghfour J, Ly S, Haidari W, et al. (2020).Treatment of keratosis pilaris and its variants: a systematic review.Systematic review supporting topical keratolytics including lactic acid and salicylic acid as better-supported options for keratosis pilaris, illustrating an AHA and BHA used for the same condition..
Glycolic acid has the smallest molecule of the common AHAs, which generally means it penetrates a bit more readily than lactic acid; lactic acid is gentler and doubles as a humectant, drawing in some moisture even as it exfoliates, which is part of why it shows up more often in formulations aimed at drier or more sensitive skin than glycolic acid does.
What BHAs Actually Do
BHAs — practically speaking, salicylic acid — are oil-soluble, which lets the molecule travel into a pore itself rather than staying on the surface the way an AHA does. That's the mechanical reason salicylic acid is the acid most associated with acne and blackhead-prone skin: it can reach inside an oil-clogged follicle in a way a water-soluble acid generally can't. Salicylic acid's keratolytic effect has trial evidence behind it in other dermatologic contexts too, such as topical wart treatment, where it outperforms placebo 2Ref 2Gibbs S, Harvey I (2006).Topical treatments for cutaneous warts.Cochrane review finding topical salicylic acid has evidence of benefit over placebo for cutaneous warts, supporting that salicylic acid's keratolytic effect is trial-backed rather than purely cosmetic marketing. — a useful data point for how real its exfoliating action is, distinct from marketing language.
Because that oil-solubility is also what lets it sit inside a pore rather than rinsing cleanly off the surface, BHA products tend to feel less immediately "gritty" or textured than an AHA can on drier skin, even though both are, at the ingredient level, doing a similar exfoliating job through different routes into the skin.
Where a BHA Fits in the Acne Treatment Picture
For acne specifically, an OTC BHA is a reasonable starting point but sits below prescription-strength options in the evidence hierarchy. Topical retinoids, benzoyl peroxide, and topical antibiotics carry the strongest guideline-level recommendations for treating acne, with azelaic acid and a handful of other options recommended more conditionally 3Ref 3Reynolds RV, Yeung H, Cheng CE, et al. (2024).Guidelines of care for the management of acne vulgaris.AAD guideline gives strong recommendations to benzoyl peroxide, topical retinoids, and topical antibiotics for acne, with azelaic acid among more conditional recommendations, positioning where an OTC BHA sits relative to prescription options. — salicylic acid isn't part of that formal ladder, which doesn't mean it's useless, but does mean it's reasonable to treat it as an adjunct rather than the main event for acne that isn't clearing with over-the-counter care alone.
A practical way to think about the distinction: a BHA cleanser or leave-on treatment can help manage mild congestion and blackheads day to day, but acne that's inflamed, cystic, or leaving marks behind is a signal to escalate toward the treatments with stronger evidence rather than simply switching to a stronger BHA formulation.
Rosacea-Prone Skin Needs a Gentler Approach to Both
Rosacea-prone skin generally does better with gentler, more targeted acids than with a strong AHA or BHA routine. Standard rosacea management leans on options like azelaic acid rather than the exfoliating acids used for acne or texture, reflecting how easily rosacea-prone skin reacts to anything that increases surface irritation 4Ref 4National Rosacea Society Expert Committee (Thiboutot D, Anderson R, Cook-Bolden F, et al.) (2020).Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee.Phenotype-directed rosacea management favors agents like azelaic acid over exfoliating acids, supporting caution with AHA/BHA use on rosacea-prone skin. — which is a reasonable caution against layering a strong AHA or BHA onto skin that's already flushing and reactive.
That doesn't mean every AHA or BHA product is off the table for someone with rosacea, but it does mean starting cautiously, patch-testing on a small area first, and watching closely for increased flushing or stinging rather than assuming a product marketed as "gentle" will behave that way on rosacea-prone skin specifically.
Eczema-Prone Skin and the Barrier Question
Eczema-prone and barrier-compromised skin is the other place both acid types call for caution rather than avoidance by default. Atopic and eczema-prone skin already has a disrupted surface barrier and heightened immune reactivity 5Ref 5National Institute of Allergy and Infectious Diseases (2024).Eczema (Atopic Dermatitis).Institutional overview describing atopic dermatitis's skin-barrier dysfunction and immune dysregulation, supporting caution with exfoliating acids on eczema-prone, barrier-compromised skin., and an exfoliating acid — AHA or BHA — works by loosening that same surface layer, which is exactly the mechanism that can aggravate a barrier that's already struggling. Introducing either acid slowly, and only on skin that's currently calm rather than actively flaring, is the more conservative approach in that situation.
Moisturizer choice matters alongside acid choice here: layering a barrier-supporting moisturizer after an acid, rather than skipping it to "let the acid work," tends to reduce the irritation that eczema-prone skin is more prone to in the first place, without meaningfully undercutting the acid's effect. A short trial period on a small test area — the inner forearm or a small patch of the jawline — before applying an acid across the whole face is a low-cost way to find out how a specific product behaves on a specific person's barrier before committing a full routine to it.
Sun Protection and Combining the Two
Both AHAs and BHAs increase how easily skin burns in the sun, which makes daily sunscreen less optional than usual while using either — UV exposure is a well-established modifiable risk factor across skin damage and skin cancer risk generally 6Ref 6National Cancer Institute (PDQ Screening and Prevention Editorial Board) (2025).Skin Cancer Prevention (PDQ®)–Health Professional Version.NCI summary of UV radiation as a modifiable skin-cancer risk factor, supporting the recommendation for daily sunscreen while using photosensitizing acids like AHAs and BHAs., and freshly exfoliated skin has less of its own natural buffer against it. Introducing one acid at a time, starting with less frequent use before building up, and watching for stinging, peeling, or redness that doesn't settle within a normal window are the practical guardrails against tipping into over-exfoliation, whether using one acid or both in rotation.
Morning sunscreen paired with an evening acid routine is the simplest way to sequence the two rather than trying to do both in the same application; acids are typically better tolerated at night, which also sidesteps any question of how they interact with a sunscreen formulation applied over them during the day.
Common questions
Related
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
When Acid Irritation Is More Than Just Sensitivity
- —burning, blistering, or raw, weeping skin after using an acid product
- —widespread hives, facial swelling, or difficulty breathing after a new skincare product
- —a rash that spreads beyond where the product was applied
Facial swelling with difficulty breathing is a 911 emergency.
This article explains general differences between AHA and BHA skincare acids and is not medical advice; it does not recommend a routine for any individual skin condition.
References
- 1.Maghfour J, Ly S, Haidari W, et al. (2020). Treatment of keratosis pilaris and its variants: a systematic review. Journal of Dermatological Treatment. PMID 32886029 ✓Systematic review supporting topical keratolytics including lactic acid and salicylic acid as better-supported options for keratosis pilaris, illustrating an AHA and BHA used for the same condition.
- 2.Gibbs S, Harvey I (2006). Topical treatments for cutaneous warts. Cochrane Database of Systematic Reviews. PMID 16855978 ✓Cochrane review finding topical salicylic acid has evidence of benefit over placebo for cutaneous warts, supporting that salicylic acid's keratolytic effect is trial-backed rather than purely cosmetic marketing.
- 3.Reynolds RV, Yeung H, Cheng CE, et al. (2024). Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology. PMID 38300170 ✓AAD guideline gives strong recommendations to benzoyl peroxide, topical retinoids, and topical antibiotics for acne, with azelaic acid among more conditional recommendations, positioning where an OTC BHA sits relative to prescription options.
- 4.National Rosacea Society Expert Committee (Thiboutot D, Anderson R, Cook-Bolden F, et al.) (2020). Standard management options for rosacea: The 2019 update by the National Rosacea Society Expert Committee. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2020.01.077Phenotype-directed rosacea management favors agents like azelaic acid over exfoliating acids, supporting caution with AHA/BHA use on rosacea-prone skin.
- 5.National Institute of Allergy and Infectious Diseases (2024). Eczema (Atopic Dermatitis). NIH / NIAID. link ✓Institutional overview describing atopic dermatitis's skin-barrier dysfunction and immune dysregulation, supporting caution with exfoliating acids on eczema-prone, barrier-compromised skin.
- 6.National Cancer Institute (PDQ Screening and Prevention Editorial Board) (2025). Skin Cancer Prevention (PDQ®)–Health Professional Version. NIH / National Cancer Institute. link ✓NCI summary of UV radiation as a modifiable skin-cancer risk factor, supporting the recommendation for daily sunscreen while using photosensitizing acids like AHAs and BHAs.
6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy